Massimo Cristofanilli
Impact in
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 0.01%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
Papers in
- Cancer Research 306
- Cancer Genomics and Diagnostics 186
- Breast Cancer Treatment Studies 114
- Oncology 465
- Cancer Cells and Metastasis 188
- HER2/EGFR in Cancer Research 139
- Cancer Treatment and Pharmacology 82
- Cancer-related Molecular Pathways 40
- Cancer Immunotherapy and Biomarkers 40
- Co-authors
- Gabriel N. HortobágyiJames M. ReubenDaniel F. HayesMichael Craig MillerGerald V. DoyleJeri MateraLeon W.M.M. TerstappenG. Thomas Budd
- Journals
- Journal of Clinical Oncology (114 papers)Cancer Research (79 papers)Cancer (30 papers)Breast Cancer Research and Treatment (27 papers)Annals of Oncology (26 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Massimo Cristofanilli
583 papers receiving 37.5k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Cancer Research 18.6k
- Oncology 26.3k
- Pulmonary and Respiratory Medicine 11.8k
- Pathology and Forensic Medicine 3.5k
- Genetics 2.0k
Countries citing papers authored by Massimo Cristofanilli
This map shows the geographic impact of Massimo Cristofanilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Cristofanilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Cristofanilli more than expected).
Fields of papers citing papers by Massimo Cristofanilli
This network shows the impact of papers produced by Massimo Cristofanilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Cristofanilli. The network helps show where Massimo Cristofanilli may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Cristofanilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 7 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 62 | |
| 5 | 2023 | 7 | |
| 6 | 2021 | 35 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 62 | |
| 9 | 2018 | 7 | |
| 10 | The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial Hit paper breakdown → | 2018 | 401 |
| 11 | 2018 | 153 | |
| 12 | 2017 | 61 | |
| 13 | 2017 | 106 | |
| 14 | 2016 | 44 | |
| 15 | 2016 | 63 | |
| 16 | 2014 | 60 | |
| 17 | 2013 | 36 | |
| 18 | 2009 | 98 | |
| 19 | 2008 | 19 | |
| 20 | Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy Hit paper breakdown → | 2005 | 1414 |
About Massimo Cristofanilli
Massimo Cristofanilli is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 600 papers that have together received 38.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (188 papers), Cancer Genomics and Diagnostics (186 papers), HER2/EGFR in Cancer Research (139 papers), Advanced Breast Cancer Therapies (127 papers), Breast Cancer Treatment Studies (114 papers), Cancer Treatment and Pharmacology (82 papers), Cancer-related Molecular Pathways (40 papers) and Cancer Immunotherapy and Biomarkers (40 papers). The work is most often cited by research in Cancer Research (18.6k citations), Oncology (26.3k citations), Pulmonary and Respiratory Medicine (11.8k citations), Pathology and Forensic Medicine (3.5k citations) and Genetics (2.0k citations). Massimo Cristofanilli has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Gabriel N. Hortobágyi, James M. Reuben, Daniel F. Hayes, Michael Craig Miller, Gerald V. Doyle, Jeri Matera, Leon W.M.M. Terstappen, G. Thomas Budd, W. Jeffrey Allard and Lajos Pusztai. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer, Breast Cancer Research and Treatment and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.